The Nobel of Medicine Rewards Discovery on the Nervous System
The Nobel Medicine Prize was handed over to the Americans David Julius and Ardem Patapoutian for their work on the nervous system. The Nobel de Medicine 2021 was awarded Monday to the American David Julius and the American of Lebano-Armenian origin Ardem Patapoutian, for their discoveries on how the nervous system feels the temperature and touch.
© Towfiqué BARBHUYA / UNSPLASH South Africa: The first Vaccine in RNA messenger on the continent in preparation
South Africa, which militates for equitable access Anti-Covid vaccines, has embarked on the design of a first African vaccine at RNA Messenger (mRNA), to terminate the continent's dependence on rich countries.
The innovative mRNA technology is to inject in the body of genetic instructions that dictate the patient's cells what to make to combat the disease. The process is used by modern modern laboratories and Pfizer-Biontech for their anti-Covid vaccines. Supported by the World Health Organization (WHO), the South African Biotechnology Afrigen company, based in Cape Town, conducts a pilot project that will call "reverse engineering" (which is to seek the principles of design a product) to reconstruct a formula close to the MRNA vaccine . The first doses should be ready for clinical trials within one year, according to the director of Afrigen, Petro Earthblache. Negotiations are underway to obtain a license agreement with the American pharmaceutical giant for production.
Coronavirus in Africa: Celebrities call the rich countries to give "urgently"
vaccines "Africa can not wait. We need doses now, "they say in an open letter published by UNICEF © Themba Hadebe / AP / SIPA The Pfizer's Anti-Covid-19 vaccine in South Africa, October 1, 2021 (Illustration) . Emergency - "Africa can not wait. We need doses now, "they say in an open letter published by UNICEF is a call for help.
to read also Covid-19: Very effective vaccination according to a French study of 22 million people
Research and development in state-of-the-art facilities, which cost about 7.5 million euros, started there. has three months. To date, just 5% of eligible Africans are fully vaccinated. Largely lagging behind the rest of the world, Africa is strongly dependent on dose imports and donations by rich countries.
"The bitter lesson we've drawn from this pandemic is that Africa is almost entirely dependent" Vaccines produced outside the continent, told AFP Richard Mihigo, Coordinator in charge of vaccines. WHO Africa. The Afrigen project aims to end it by locally developing an innovative vaccine, adapted to climate conditions in Africa. "What we are looking for is a second generation vaccine," says Martin Friede, Coordinator for Vaccines for WHO in Geneva.
Malaria: WHO recommends massive deployment in children of the first vaccine against this infectious disease
This vaccine, manufactured by the GlaxoSmithKline British laboratory, aims to combat the disease that kills about half a million people each Year, almost all in sub-Saharan Africa, including 260,000 children under 5 years of age. © provided by FRANCINFO A major step forward. The World Health Organization approved Wednesday 6 October the very first vaccine to prevent malaria. This vaccine could save the lives of tens of thousands of children around the world every year. "It's a historic moment.
to read also Covid-19 vaccine: the vaccination of the children in question
"We have to start with a thousand of Moderna and bring us closer as possible," he continues. But the idea is to develop a vaccine "more adapted to low-income countries". While existing mRNA vaccines should be stored at low temperatures, the Afrigen formula will ideally require little or no refrigeration. "Africa must become autonomous in the production of vaccines over the next 20 years," says Mr. Friede. Once the formula is developed, Afrigen plans to train other African countries in the manufacture of the vaccine. South African BioVac, located in the same complex as Afrigen, will be the first to produce the new commercial vaccine.
created by UNITAID - International Organization for Medicinal Purchasing for Poor Countries - The Patent Pool Medicines (MPP), which negotiates treatment licenses with patent holders, conducts the talks with Moderna. With a little luck, "we could get an agreement so that they do not say their patents," said Charles Gore last month, director of the MPP. The giants of the pharmaceutical industry have so far resisted the pressures for lift patents on anti-Covid vaccines. South Africa and India in mind have militated for a temporary lifting allowing countries in lack of doses of producing cheaper generics.
for Macron, France must "assume its share of Africanity"
© Copyright 2021, Obs "We have a debt towards Africa, [...] a continent that fascinates the whole world, which sometimes in scare others "" We can not have a future project for France if it does not assume its share of Africanity, "launched this Friday, October 8, President Emmanuel Macron at the Africa Summit France, stressing that "nearly seven million French people are intimately, familially related to Africa." "We have a debt towards Africa", "a continent that fascinates the whole world, wh
Last week, Moderna announced its intention to build a state-of-the-art mRNA plant in Africa, which will produce up to 500 million doses of vaccines a year. For the moment, nor date or place have been specified. The Afrigen project is funded by the WHO COVAX initiative, for equitable access to vaccines. South Africa is officially the African country most affected by the pandemic, with more than 2.9 million cases and 88,300 deaths. Doses of the Johnson & Johnson American laboratory vaccine are packaged by the Aspen pharmaceutical giant in GQeberha (EST). And a similar agreement was passed between American Pfizer and South African BioVac laboratories in Cape Town. to read also the Africa-France summit of Emmanuel Macron, a "trompe-l'oeil break"?
Moderna (+ 2%) welcomes the green light to the recalling anti-COVID vaccine in the United States .
Laboratories involved in vaccines and treatments against coronaviruses are under the fire of the projectors Thursday in Wall Street, the next day of the fire Green of the US medicine agency, the FDA, at the recall doses of the Vaccines Anti-Covid of Moderna and Johnson & Johnson. The reminder of the Pfizer / Biontech vaccine has already been authorized at the end of September by the FDA, and this third dose was very effective at 95.6%, the two groups announced on Thursday.